[go: up one dir, main page]

BR9202575A - Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose - Google Patents

Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose

Info

Publication number
BR9202575A
BR9202575A BR929202575A BR9202575A BR9202575A BR 9202575 A BR9202575 A BR 9202575A BR 929202575 A BR929202575 A BR 929202575A BR 9202575 A BR9202575 A BR 9202575A BR 9202575 A BR9202575 A BR 9202575A
Authority
BR
Brazil
Prior art keywords
vector
microorganism
virus
protected
polypeptide
Prior art date
Application number
BR929202575A
Other languages
English (en)
Inventor
Mary-Helen Binger
Luis Pasamontes
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9202575A publication Critical patent/BR9202575A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR929202575A 1991-07-12 1992-07-10 Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose BR9202575A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/729,099 US5403581A (en) 1991-07-12 1991-07-12 Coccidiosis vaccines

Publications (1)

Publication Number Publication Date
BR9202575A true BR9202575A (pt) 1993-03-16

Family

ID=24929576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929202575A BR9202575A (pt) 1991-07-12 1992-07-10 Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose

Country Status (19)

Country Link
US (2) US5403581A (pt)
EP (1) EP0522482A3 (pt)
JP (1) JP3450018B2 (pt)
KR (1) KR100244828B1 (pt)
AU (1) AU667811B2 (pt)
BR (1) BR9202575A (pt)
CA (1) CA2073588A1 (pt)
CZ (1) CZ285116B6 (pt)
FI (1) FI923200A7 (pt)
HU (2) HU217420B (pt)
IE (1) IE922261A1 (pt)
IL (1) IL102448A0 (pt)
MX (1) MX9204052A (pt)
NO (1) NO922728L (pt)
NZ (1) NZ243471A (pt)
RU (1) RU2130072C1 (pt)
SK (1) SK281606B6 (pt)
UY (1) UY23445A1 (pt)
ZA (1) ZA925103B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
US5674484A (en) * 1991-07-12 1997-10-07 Pfizer Inc. Continuous cell line and vaccine against avian coccidia
ES2192559T3 (es) * 1993-11-12 2003-10-16 Akzo Nobel Nv Vacuna para la proteccion de aves de corral contra la coccidiosis.
MX9709870A (es) 1995-06-07 1998-03-31 Pfizer Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis.
US6500438B2 (en) 1995-06-07 2002-12-31 Pfizer Incorporated In ovo vaccination against coccidiosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
WO2000018895A1 (en) 1998-09-25 2000-04-06 The Children's Medical Center Corporation Short peptides which selectively modulate the activity of protein kinases
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
CN1547607A (zh) 2001-08-30 2004-11-17 制备卵囊的改进方法
US6924135B2 (en) * 2003-08-29 2005-08-02 Zeon Corporation DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
EP1666489B1 (en) * 2004-12-01 2007-11-21 Zeon Corporation DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof
RU2409385C2 (ru) * 2006-03-30 2011-01-20 Эмбрекс, Инк. Способ иммунизации птицы против инфекции, вызванной бактериями clostridium

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) * 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
EP0135712A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
EP0135073A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
US4650676A (en) * 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
CA1340520C (en) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
EP0190254A4 (en) * 1984-07-05 1987-03-09 Genex Corp GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF.
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
ATE73494T1 (de) * 1985-12-03 1992-03-15 Solvay Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose.
EP0241139A3 (en) * 1986-03-13 1989-04-19 Merck & Co. Inc. Anti-idiotypic vaccine for coccidiosis
SU1396603A1 (ru) * 1986-04-25 1990-05-07 Inst Obshchej Genetiki Im N I ЧЕТЦФєЛИБИгИБЭ ЬОБъФЛјИБЭ ј И Т Ч С Ефу јОЭ ГТЧЛИЛИїБ ФлгБїЕИЦВk ЛИјл»ЛЧлёэЛз в Ц в`ѕлИТ»ЛЛ В ТОЕгТБз ЕвГИЕЩЙГИЙБ ГЦУЙ
CA1340838C (en) * 1986-08-14 1999-12-07 Michael Wallach Coccidiosis vacine
AU631107B2 (en) * 1987-03-06 1992-11-19 Synergen, Inc. Polypeptides useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
IL85980A (en) * 1987-04-16 1992-03-29 Embrex Inc Disease control in avian species by embryonal vaccination with a nonreplicating immunogen
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
US4973551A (en) * 1988-01-15 1990-11-27 Merck & Co., Inc. Vector for the expression of fusion proteins and protein immunogens
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
NZ227597A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
US5122471A (en) * 1988-02-12 1992-06-16 The United States Of America As Represented By The Secretary Of Agriculture Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response
ZA889230B (en) * 1988-02-12 1989-08-30 Us Agriculture Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response and method of producing the same
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
ZA924203B (en) * 1991-06-18 1993-03-31 Akzo Nv Coccidiosis poultry vaccine

Also Published As

Publication number Publication date
IE922261A1 (en) 1993-01-13
NO922728D0 (no) 1992-07-10
IL102448A0 (en) 1993-01-14
SK281606B6 (sk) 2001-05-10
NZ243471A (en) 1994-06-27
NO922728L (no) 1993-01-13
ZA925103B (en) 1993-12-13
AU1945992A (en) 1993-01-14
HU217420B (hu) 2000-01-28
MX9204052A (es) 1993-01-01
HU211673A9 (en) 1995-12-28
AU667811B2 (en) 1996-04-18
CZ285116B6 (cs) 1999-05-12
KR100244828B1 (ko) 2000-02-15
US5403581A (en) 1995-04-04
UY23445A1 (es) 1993-01-04
FI923200A7 (fi) 1993-01-13
JPH05306298A (ja) 1993-11-19
JP3450018B2 (ja) 2003-09-22
SK216792A3 (en) 1994-09-07
US5688513A (en) 1997-11-18
CA2073588A1 (en) 1993-01-13
EP0522482A2 (en) 1993-01-13
EP0522482A3 (en) 1993-09-08
RU2130072C1 (ru) 1999-05-10
HU9202281D0 (en) 1992-10-28
HUT65448A (en) 1994-06-28
CZ216792A3 (en) 1993-09-15
FI923200A0 (fi) 1992-07-10

Similar Documents

Publication Publication Date Title
BR9202575A (pt) Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
BR9101466A (pt) Catalisador de combustao de oxido complexo de terra rara,processo para preparacao desto catalisador e uso deste catalisador
AR020054A1 (es) COMPOSICIoN QUE COMPRENDE UN ADENOVIRUS
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
NZ333500A (en) Vaccines comprising HIV gp120 envelope polypeptides from vaccinees vaccinated with an earlier HIV gp120 vaccine and subsequently infected with HIV
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
BR9709845A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral e processo para aumentar a estabilidade química de uma preparação de insulina
HUP9901112A2 (hu) Szintetikus HIV-gének
BR9811475A (pt) Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
PT100245A (pt) Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
AU8113591A (en) Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
HUP9900935A2 (hu) Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
DE69531793D1 (de) Immunogene zubereitungen
EE9800334A (et) Helicobacter pylor' iga seotud nukleiinhapete ja aminohapete järjestused ja nendest tuletatud vaktsiinikompositsioonid
BRPI9600729B8 (pt) vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada
NO982708L (no) Nye fenylamidinderivater, fremgangsmÕte for fremstilling derav og deres anvendelse som legemidler
DE10399004I1 (de) Klonierung und Expression von Wirtsschuetzenden immunogenen des Infektioesen Bursavirus (ibdv)
BR9506862A (pt) Sequência de nucleotídeos polipeptídeo vetor célula hospedeira planta hospedeira ou parte da mesma planta ou parte da mesma e processo para alterar as caracteristica fisicas da uma planta ou parte da mesma
ATE221786T1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
PT82282B (pt) Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/455 (2006.01), A61K 39/00 (2006.0